October 02, 2018
New Glenmark paper: TLA and clonal derivation assessment of (CHO) cell lines
September 13, 2018
Cergentis & Princess Máxima Center collaborate on MRD test development for leukemia and solid tumours
June 13, 2018
Cergentis’ CEO invited to present TLA technology at ACTIP meeting in Dusseldorf
November 15, 2017
Meet us at the Cell Therapy Manufacturing & Gene Therapy Congress next month
October 11, 2017
Meet us at the 6th Cell Culture & Bioprocessing Congress in London